Compounds > dihydroxyphenylalanine
Page last updated: 2024-10-18

dihydroxyphenylalanine and Clinically Isolated CNS Demyelinating Syndrome

dihydroxyphenylalanine has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 7 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sacks, OW1
Jenkins, R1
Araki, S1
Kameyama, M1
Donaldson, IM1
Mastaglia, FL1
Grainger, K1
Kee, F1
Sadka, M1
Lefroy, R1
Atarashi, J1
Terashi, A1

Reviews

3 reviews available for dihydroxyphenylalanine and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
[Recent trend in neurology].
    Naika. Internal medicine, 1970, Volume: 25, Issue:1

    Topics: Cerebrovascular Disorders; Demyelinating Diseases; Diet Therapy; Dihydroxyphenylalanine; Epilepsy; H

1970
[Neurology].
    Naika. Internal medicine, 1972, Volume: 29, Issue:1

    Topics: Autonomic Nervous System; Brain Diseases; Cerebrovascular Disorders; Demyelinating Diseases; Dihydro

1972
[Recent progress in neurology].
    Naika. Internal medicine, 1971, Volume: 27, Issue:1

    Topics: Abdomen; Brain Death; Cerebrovascular Disorders; Demyelinating Diseases; Diffuse Cerebral Sclerosis

1971

Other Studies

4 other studies available for dihydroxyphenylalanine and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
L-dopa for progressive suparanulcear palsy.
    Lancet (London, England), 1969, Sep-13, Volume: 2, Issue:7620

    Topics: Aged; Bulbar Palsy, Progressive; Demyelinating Diseases; Dihydroxyphenylalanine; Humans; Male; Ophth

1969
L-dopa for progressive supranuclear palsy.
    Lancet (London, England), 1969, Oct-04, Volume: 2, Issue:7623

    Topics: Bulbar Palsy, Progressive; Demyelinating Diseases; Dihydroxyphenylalanine; Humans; Male; Ophthalmopl

1969
The treatment of progressive supranuclear palsy with L-dopa.
    Australian and New Zealand journal of medicine, 1973, Volume: 3, Issue:4

    Topics: Aged; Bulbar Palsy, Progressive; Demyelinating Diseases; Dihydroxyphenylalanine; Female; Humans; Mid

1973
Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome) clinical and electrophysiological observations in eleven cases.
    Proceedings of the Australian Association of Neurologists, 1973, Volume: 10, Issue:0

    Topics: Aged; Basal Ganglia Diseases; Bulbar Palsy, Progressive; Demyelinating Diseases; Dihydroxyphenylalan

1973